GENERIC NAME:

Tegoprazan

FORM:

Film-Coated Tablet

INDICATION AND USAGE:

For treatment of Erosive Gastroesophageal Reflux Disease, Non-Erosive Gastroesophageal Reflux Disease, and Gastric Ulcer.

Eradication of H.pylori concurrently given with appropriate antibiotic therapy treatment in patients with peptic ulcer and/or chronic atrophic gastritis.

DOSAGE AND ADMINISTRATION:

Adult Population:

Treatment of Erosive Gastroesophageal Reflux Disease

• 50 mg once daily for 4 weeks.
• For patients who do not heal or have persistent symptoms after 4 weeks, additional 4-week treatment may be considered.

Treatment of Non-Erosive Gastroesophageal Reflux Disease

• 50 mg once daily for 4 weeks.

Treatment of Gastric Ulcer

• 50 mg once daily for 8 weeks.

Eradication of H.pylori concurrently given with appropriate antibiotic therapy treatment in patients with peptic ulcer and/or chronic atrophic gastritis.

• Patients with H.pylori infection should be treated with eradication therapy. Tegoprazan 50mg, clarithromycin 500mg and amoxicillin 1g are orally administered twice daily for 7 days.

K-CAB can be taken without regard to food.

AVAILABILITY:

Box of 30 Film-Coated Tablets